A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
Clinical trial NCT02867735 · COMPLETED
Trial details
- NCT number
- NCT02867735
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-21
- Primary completion
- 2018-02-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.